Updated Jul 16, 2026
Gallagher Kathleen P. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $9K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-22 | RNA | Atrium Therapeutics, Inc. | A — Grant or award | 102.5K | $0.00 | |
| 2026-02-27 | RNAM | Avidity Biosciences, Inc. | D — Derivative transaction | 80.3K | — | |
| 2025-09-02 | RNAM | Avidity Biosciences, Inc. | S — Open-market sale | 188 | $47.42 | $9K |
Gallagher Kathleen P. is a corporate insider — currently tracked as Insider of Atrium Therapeutics, Inc. (RNA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($9K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gallagher Kathleen P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.